Latest news

Jeremie Trochu, CEO of the Ardena Group, is proposed as a new member of the board of directors of Nanologica AB. The proposal has been presented by Nanologica’s main owner Flerie Invest AB in connection with Nanologica’s acquisition of Ardena Södertälje AB. The proposal will be resolved at the Extraordinary General Meeting on March 4.   The proposal to elect Jeremie Trochu to Nanologica’s board of directors marks the continued collaboration between Nanologica and Ardena

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, OR ANY OTHER JURISDICTION IN WHICH SUCH DISTRIBUTION REQUIRES A PROSPECTUS, REGISTRATION OR OTHER MEASURES IN ADDITION TO THOSE REQUIRED BY SWEDISH LAW, IS PROHIBITED, OR OTHERWISE CONTRAVENES APPLICABLE RULES IN SUCH JURISDICTION OR CANNOT BE MADE WITHOUT THE APPLICATION OF AN EXEMPTION FROM SUCH

Nanologica AB (publ) (“Nanologica”) has today entered into an agreement and completed the acquisition of all shares in Ardena Södertälje AB (“Syntagon”) from Ardena Sweden (the “Seller”). The purchase price amounts to approximately SEK 8.6 million and will be paid in the form of newly issued shares in Nanologica. Syntagon is a Contract Development and Manufacturing Organization with just over 45 employees, which in 2025 had sales of approximately SEK 80 million. Nanologica believes that

Nanologica has received an order for a non-silica-based purification media from a customer in Asia. The order value amounts to approximately SEK 1.5 million. “To broaden our portfolio of chromatography media, we have a development program for additional applications. We are at an early stage and are therefore pleased to already receive a larger order. The visibility of revenue on this program is low, but in the long term it has the potential to provide